Search results for "Edema"

showing 10 items of 625 documents

Comparison of piezosurgery and conventional rotary instruments in schneider’s membrane sinus lifting: A pilot randomized trial

2020

Background The present study aimed to evaluate and compare the postoperative effects of the piezoelectric device and conventional rotary instruments in Schneider’s membrane sinus lifting procedure. Material and Methods Twenty patients requiring bilateral maxillary bone graft augmentation in the posterior maxillary region were selected. Piezoelectric surgery was performed on one side and conventional surgery with a rotary diamond bur on the other. Postoperative pain, swelling, edema, and mouth opening were evaluated at one hour and two and seven days after the procedures. All variables were submitted to Friedman or Wilcoxon tests at a 5% significance level. Results The comparison between gro…

Piezoelectric surgerybusiness.industryResearchmedicine.medical_treatmentSinus liftDentistryOsteotomylaw.inventionmedicine.anatomical_structureRandomized controlled triallawStatistical significanceEdemamedicineOdontostomatology for the Disabled or Special Patientsmedicine.symptombusinessGeneral DentistryPiezosurgeryUNESCO:CIENCIAS MÉDICASSinus (anatomy)Journal of Clinical and Experimental Dentistry
researchProduct

Œdème maculaire diabétique : diagnostic et bilan pré-thérapeutique

2015

Pre treatmentmedicine.medical_specialtybusiness.industryDiabetic macular edema030209 endocrinology & metabolismDiabetic retinopathymedicine.diseaseWork-up03 medical and health sciencesOphthalmology0302 clinical medicineOphthalmology030221 ophthalmology & optometrymedicinebusinessMacular edemaJournal Français d'Ophtalmologie
researchProduct

Urticaria in Pediatrics and During Pregnancy and Lactation: Highlights on Epidemiology, Diagnosis, and Management

2021

Chronic urticaria (CU) in children as in adults is characterized by the presence of itchy wheals, angioedema, or both daily or almost daily for at least 6 weeks. Most cases of urticaria in the pediatric age group are acute [1–4]. CU is sub-classified as spontaneous (occurring without a known trigger) or inducible. There are also cases of spontaneous and inducible forms that co-exist. The chronic subtypes occur continuously but also recurrently, often in association with infections. In this chapter we will touch briefly on the clinical presentation, diagnosis, and management of acute urticaria in children. However, our primary goal is to highlight key findings regarding the epidemiology, dia…

PregnancyPediatricsmedicine.medical_specialtyAcute urticariaAngioedemabusiness.industryPediatric agemedicine.diseasemedicine.anatomical_structureimmune system diseasesLactationEpidemiologyMedicineApproaches of managementmedicine.symptomskin and connective tissue diseasesbusinessChronic urticaria
researchProduct

Lymphoscintigraphy for the diagnosis of extremity lymphedema: Current controversies regarding protocol, interpretation, and clinical application

2019

Appropriate diagnosis, staging and a further selection of the best treatment are fundamental for the management of patients with extremity lymphedema. Several clinical and imaging tools have been described for these purposes. Lymphoscintigraphy is still considered the gold standard imaging modality for diagnosing lymphedema. However, protocol variability and poor image resolution can make the interpretation challenging. Here, we reviewed technical aspects of lymphoscintigraphy, interpretation of the lymphoscintigraphy findings, staging, and its clinical application.

Protocol (science)medicine.medical_specialtybusiness.industryGeneral MedicineGold standard (test)medicine.disease03 medical and health sciencesextremity lymphedema; lymphatic microsurgery; lymphedema diagnosis; Lymphedema Grading System; lymphoscintigraphy; Humans; Lymphedema; Lymphoscintigraphy0302 clinical medicineLymphedemaOncology030220 oncology & carcinogenesismedicineHumans030211 gastroenterology & hepatologySurgeryLymphedemaRadiologybusinessLymphoscintigraphyJournal of Surgical Oncology
researchProduct

Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review.

2013

Hereditary angioedema (HAE) due to C1 esterase inhibitor (HAE-C1-INH) deficiency is a rare genetic disorder presenting with recurrent episodes of skin swellings, abdominal pain attacks, and potentially fatal laryngeal edema. This study was designed to review the efficacy and safety of pasteurized, human, plasma-derived C1-INH concentrate for the treatment of patients with HAE-C1-INH. A systematic search of electronic databases up to December 2011 was performed without language or date restrictions. Two reviewers completed the study selection using predefined inclusion criteria, tabulated, and analyzed the data. The data were inappropriate for meta-analysis; thus, a qualitative synthesis was…

Pulmonary and Respiratory MedicineAdultMaleAbdominal painmedicine.medical_specialtyAdolescentPlacebolaw.inventionYoung AdultQuality of lifeRandomized controlled triallawInternal medicineImmunology and AllergyMedicineHumansYoung adultChildRandomized Controlled Trials as TopicHereditary Angioedema Types I and IIbusiness.industryGeneral Medicinebacterial infections and mycosesmedicine.diseaseSystematic reviewTreatment OutcomeChild PreschoolHereditary angioedemaObservational studyFemalemedicine.symptombusinessComplement C1 Inhibitor ProteinAllergy and asthma proceedings
researchProduct

Blindness, tetraspasticity, and other signs of irreversible brain damage in hereditary angioedema

2017

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentImmunologyBrain damageLaryngeal EdemaBlindness03 medical and health sciences0302 clinical medicinemedicineImmunology and AllergyHumans030212 general & internal medicineHypoxia BrainBlindnessHereditary Angioedema Types I and IIbusiness.industryLaryngeal Edemamedicine.diseaseDermatologyMuscle SpasticityHereditary angioedemamedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.

2015

BACKGROUND Although treatment with C1 esterase inhibitor (C1-INH) concentrate is well established for hereditary angioedema (HAE) attacks in general, data that assess its efficacy for cutaneous attack treatment are sparse. OBJECTIVE To assess efficacy of plasma-derived, nanofiltered C1-INH concentrate for cutaneous attack treatment by comparing treated attacks from the uncontrolled I.M.P.A.C.T.2 study with historical data for untreated attacks. METHODS Cutaneous attack data from patients with HAE who were treated for cutaneous edema with 20 IU/kg body weight C1-INH concentrate in the uncontrolled I.M.P.A.C.T.2 study (38 patients) were compared with data from untreated patients from an histo…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentUntreated groupPeripheral edemaGastroenterologySeverity of Illness IndexYoung AdultInternal medicineSeverity of illnessmedicineImmunology and AllergyHumansYoung adultChildAgedEnd pointbusiness.industryAngioedemas HereditaryGeneral MedicineArticlesMiddle Agedmedicine.diseasePeripheralC1 esteraseTreatment OutcomeHereditary angioedemaDisease ProgressionFemalemedicine.symptombusinessComplement C1 Inhibitor ProteinAllergy and asthma proceedings
researchProduct

Economic costs associated with acute attacks and long-term management of hereditary angioedema.

2010

Background Hereditary angioedema (HAE) is a rare autosomal dominant disorder characterized by recurrent acute attacks of swelling of the larynx, abdomen, and periphery. Objective To assess the economic burden associated with acute attacks and long-term management of HAE. Methods Burden was assessed via a Web-based survey of HAE patients (≥18 years old) that solicited information on attack characterization, short-term treatment, long-term disease management, impact on work, and patient costs. A standardized instrument, the Work Productivity and Activity Impairment questionnaire, was included to assess impact on work productivity. Standard medical costs and US average wage costs were assigned…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyEmergency Medical Servicesmedia_common.quotation_subjectImmunologyWageDrug CostsIndirect costsCost of IllnessEconomic costSurveys and QuestionnairesLong term managementmedicineImmunology and AllergyHumansDisease management (health)Hospital CostsProductivityhealth care economics and organizationsmedia_commonbusiness.industryAngioedemas HereditaryEmergency departmentHealth Care Costsmedicine.diseaseHospitalizationHealth Care SurveysEmergency medicineHereditary angioedemaAcute DiseasePhysical therapyFemalebusinessAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: A systematic review

2008

In vitro and in vivo clinical and experimental data have suggested that leukotrienes play a key role in inflammatory reactions of the skin. Antileukotriene drugs, ie, leukotriene receptor antagonists and synthesis inhibitors, are a class of anti-inflammatory drugs that have shown clinical efficacy in the management of asthma and in rhinitis with asthma. We searched MEDLINE database and carried out a manual search on journals specializing in allergy and dermatology for the use of antileukotriene drugs in urticaria. Montelukast might be effective in chronic urticaria associated with aspirin (ASA) or food additive hypersensitivity or with autoreactivity to intradermal serum injection (ASST) wh…

Pulmonary and Respiratory MedicineAllergyzafirlukastmedicine.medical_treatmentleukotrienes anti-inflammatory drugsReviewCold urticariaantihistamineimmune system diseasesparasitic diseasesImmunology and AllergyMedicineZafirlukastVibratory angioedemaskin and connective tissue diseasesMontelukastbusiness.industryleukotriene receptor antagonistsZileutonmedicine.diseaseAntileukotrienechronic idiopathic urticariamontelukastImmunologyAntihistaminebusinessmedicine.drug
researchProduct

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, a…

2008

Background We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) in 2004. Objective To ensure that this consensus remains current. Methods In collaboration with the Canadian Network of Rare Blood Disorder Organizations, we held the second Canadian Consensus discussion with our international colleagues in Toronto, Ontario, on February 3, 2006, and reviewed its content at the Fifth C1 Inhibitor Deficiency Workshop in Budapest on June 2, 2007. Papers were presented by international investigators, and this consensus algorithm approach resulted. Results This consensus algorithm …

Pulmonary and Respiratory MedicineConsensus algorithmmedicine.medical_specialtyCanadaC1 inhibitor deficiencyConsensus Development Conferences as TopicInternational CooperationImmunologyMEDLINEEcallantidemedicineImmunology and AllergyHumansHungarybusiness.industryAngioedemas HereditaryState of the art reviewEvidence-based medicinemedicine.diseaseBlood DisorderFamily medicineHereditary angioedemaControlled Clinical Trials as TopicbusinessAlgorithmsmedicine.drugAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct